| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |